October 28, 2024- MedPro has announced a strategic partnership with Champion Manufacturing. This collaboration will enable MedPro to provide comprehensive national sales coverage for the Champion Select Collection, a prominent line of healthcare seating solutions, across the acute, non-acute, and government markets. Champion manufacturing is a leading manufacturer of … [Read more...]
Medtronic receives FDA approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter
October 28, 2024- Medtronic plc announced U.S. Food and Drug Administration (FDA) approval of the Affera™ Mapping and Ablation System with Sphere-9™ Catheter, an all-in-one, high-density (HD) mapping and pulsed field (PF) and radiofrequency (RF) ablation catheter for treatment of persistent atrial fibrillation (AFib) and for RF ablation of cavotricuspid isthmus (CTI) dependent … [Read more...]
Cleveland Clinic webinar for ANAE Members
October 28, 2024- Please join us November 22 at 2:00 PM ET for The Association of National Account Executive’s Supply Chain Leader Learning Series Webinar with Geoff Gates, Senior Director, SCSS P2P & Technology at Cleveland Clinic. John Pritchard, President of ANAE, will sit down with Geoff to discuss unique aspects of their health system, current priorities, collaborative … [Read more...]
BD named among the 100 Best Corporate Citizens of 2024
October 28, 2024- BD announced it has been named as one of the 100 Best Corporate Citizens of 2024 by 3BL, ranking second in the health care equipment and services industry for its second consecutive year. The 100 Best Corporate Citizens list recognizes outstanding environmental, social and governance transparency and performance among 1,000 of the largest U.S. public … [Read more...]
Production at Baxter’s North Cove facility anticipated to restart next week
October 25, 2024- Baxter recently reported that the company anticipates restarting the highest-throughput IV solutions manufacturing line within the next week, barring any unanticipated developments. Initial batches will be manufactured concurrently with ongoing quality activities and will only be released in accordance with applicable regulatory requirements to ensure the … [Read more...]
Advisory Committee on Immunization Practices recommends PREVNAR 20® for adults aged 50 and older
October 25, 2024- Pfizer Inc. announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practice (ACIP) voted to expand its recommendation for the use of certain pneumococcal vaccines, including PREVNAR 20 ® (20-valent Pneumococcal Conjugate Vaccine) for all adults aged 50 and older. This recommendation is pending final … [Read more...]
Thermo Fisher Scientific reports Third Quarter 2024 results
October 25, 2024- Thermo Fisher Scientific Inc. reported its financial results for the third quarter ended September 28, 2024.Third quarter revenue was $10.60 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.25. Third quarter adjusted EPS was $5.28. Revenue for the quarter was $10.60 billion in 2024 versus $10.57 billion in 2023. Growth in revenue, organic … [Read more...]
Last chance! Register now for PWH Professional Development Course
October 25, 2024- Join PWH for the 2024 Professional Development Course: “The NeXt Factor - Elevate Your Personal Brand and Professional Presence,” November 1 & 8, from 10 AM – 1:30 PM ET. In this two-session course, develop self-confidence in your leadership abilities by building your unique leadership brand. Learn to elevate your leadership brand to expand your … [Read more...]
Abbott initiates new clinical trial to improve outcomes in patients with advanced heart failure
October 25, 2024- Abbott has announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy options. The TEAM-HF trial, which is planned to enroll up to 850 patients across 75 sites worldwide, will measure pulmonary artery pressures (PAP) using Abbott's CardioMEMS™ HF … [Read more...]
Henry Schein to participate in Investor Conferences in November
October 25, 2024- Henry Schein, Inc. announced that the Company will present at the following investor conferences in November including the Jefferies London Healthcare Conference on November 19, 2024, at 10:30 a.m. Greenwich Mean Time/5:30 a.m. Eastern Standard Time and Stifel’s Healthcare Conference at Lotte New York Palace Hotel, New York, on November 18, 2024, at 9:45 a.m. … [Read more...]